7,764 Shares in The Cooper Companies, Inc. $COO Acquired by Pallas Capital Advisors LLC

Pallas Capital Advisors LLC acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 7,764 shares of the medical device company’s stock, valued at approximately $557,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in COO. New York Life Investment Management LLC raised its position in shares of Cooper Companies by 0.6% during the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after acquiring an additional 158 shares during the last quarter. Root Financial Partners LLC boosted its holdings in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares during the last quarter. Essential Partners LLC boosted its holdings in Cooper Companies by 23.4% in the first quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock valued at $62,000 after acquiring an additional 166 shares during the last quarter. Allworth Financial LP increased its position in Cooper Companies by 14.1% in the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after purchasing an additional 167 shares during the period. Finally, SJS Investment Consulting Inc. increased its position in Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after purchasing an additional 187 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Trading Up 1.3%

NASDAQ COO opened at $76.73 on Thursday. The firm has a market cap of $14.96 billion, a P/E ratio of 65.03, a P/E/G ratio of 1.98 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The stock’s 50-day moving average is $71.59 and its 200-day moving average is $71.16. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same period in the previous year, the firm earned $0.96 EPS. Cooper Companies’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on COO. Robert W. Baird dropped their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, June 5th. Mizuho set a $85.00 target price on shares of Cooper Companies and gave the company an “outperform” rating in a research note on Thursday, June 4th. UBS Group assumed coverage on shares of Cooper Companies in a research report on Tuesday, July 28th. They set a “neutral” rating and a $75.00 price target for the company. Wells Fargo & Company reissued a “sell” rating and set a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. Finally, Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $81.64.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.